A Phase I Study to Evaluate the Effect of Darunavir/Ritonavir and Lopinavir/Ritonavir on GSK2248761 Pharmacokinetics and to Assess the Effect of GSK2248761 on CYP450 Probe Drugs in Healthy Adult Subjects.
Phase of Trial: Phase I
Latest Information Update: 15 Sep 2010
At a glance
- Drugs Darunavir; Fosdevirine; Lopinavir/ritonavir; Ritonavir
- Indications HIV infections; HIV-1 infections
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 15 Sep 2010 Actual patient number (n=24) reported at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy.
- 15 Sep 2010 Results from this trial were presented at 50th Interscience Conference on Antimicrobial Agents and Chemotherapy.
- 02 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.